Elite Pharmaceuticals (STU:ETF) Change In Inventory : €-5.36 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Elite Pharmaceuticals Change In Inventory?

Elite Pharmaceuticals's change in inventory for the quarter that ended in Dec. 2023 was €0.82 Mil. It means Elite Pharmaceuticals's inventory declined by €0.82 Mil from Sep. 2023 to Dec. 2023 .

Elite Pharmaceuticals's change in inventory for the fiscal year that ended in Mar. 2023 was €-2.63 Mil. It means Elite Pharmaceuticals's inventory increased by €2.63 Mil from Mar. 2022 to Mar. 2023 .

Elite Pharmaceuticals's Total Inventories for the quarter that ended in Dec. 2023 was €13.14 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Elite Pharmaceuticals's Days Inventory for the quarter that ended in Dec. 2023 was 160.44.

Inventory Turnover measures how fast the company turns over its inventory within a year. Elite Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.57.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Elite Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.96.

Elite Pharmaceuticals Change In Inventory Historical Data

The historical data trend for Elite Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elite Pharmaceuticals Change In Inventory Chart

Elite Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Inventory

Get a 7-Day Free Trial

0.34

-0.73

-1.57

-2.63

Elite Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-1.07	-0.89	-1.49	-3.80	0.82

Elite Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-5.36 Mil.

Elite Pharmaceuticals (STU:ETF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Elite Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	13.7005	/	7.792	*	365 / 4
	=	160.44

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Elite Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	7.792	/	13.7005
	=	0.57

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Elite Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	13.7005	/	14.249
	=	0.96

Elite Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of Elite Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Elite Pharmaceuticals (STU:ETF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elite Pharmaceuticals Inc (STU:ETF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

ELTP:USA

Address

165 Ludlow Avenue, Northvale, NJ, USA, 07647

Website

https://www.elitepharma.com

Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.

Elite Pharmaceuticals (STU:ETF) Headlines

No Headlines